Last 16.23 INR
Change Today -1.80 / -9.98%
Volume 46.6K
AD On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:29 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

aarey drugs & pharmaceut (AD) Snapshot

Open
19.25
Previous Close
18.03
Day High
19.30
Day Low
16.23
52 Week High
07/9/14 - 22.76
52 Week Low
10/4/13 - 9.02
Market Cap
272.9M
Average Volume 10 Days
113.0K
EPS TTM
0.17
Shares Outstanding
16.8M
EX-Date
--
P/E TM
96.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for AAREY DRUGS & PHARMACEUT (AD)

Related News

No related news articles were found.

aarey drugs & pharmaceut (AD) Related Businessweek News

No Related Businessweek News Found

aarey drugs & pharmaceut (AD) Details

Aarey Drugs & Pharmaceuticals Limited manufactures and trades in pharmaceutical raw materials, chemicals, pharmaceuticals ingredients, API’s drugs, food colours, and flavours primarily in India. The company’s API products include metronidazole and metronidazole benzoate; and pharma products comprise 2-methyl-5-nitroimidazole and 1-methylimidazole. It also imports and distributes various industrial chemicals and solvents, including methanol, toluene, xylene, acetic acid (glacial), acetone, liquor ammonia, and IPA. The company was formerly known as Niharika Textiles & Chemicals Private Limited and changed its name to Aarey Drugs & Pharmaceuticals Limited in March 1993. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.

Founded in 1990

aarey drugs & pharmaceut (AD) Top Compensated Officers

Managing Director, Director, Member of Audit ...
Total Annual Compensation: 300.0K
Compensation as of Fiscal Year 2013.

aarey drugs & pharmaceut (AD) Key Developments

Aarey Drugs & Pharmaceuticals Ltd. Announces Standalone Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2014

Aarey Drugs & Pharmaceuticals Ltd. announced standalone audited earnings results for the fourth quarter and full year ended March 31, 2014. For the quarter, the company reported net sales of INR 369.891 million compared with INR 490.783 million for the same period a year ago. Operating loss before interest was INR 9.425 million compared with INR 3.553 million for the same period a year ago. Loss from ordinary activities before tax was INR 1.015 million compared with INR 2.944 million for the same period a year ago. Net loss was INR 2.504 million or INR 0.15 per basic and diluted share before and after extraordinary items compared with INR 5.387 million or INR 0.32 per basic and diluted share before and after extraordinary items for the same period a year ago. For the full year, the company reported net sales of INR 1,997.260 million compared with INR 1,723.074 million for the same period a year ago. Operating profit before interest was INR 5.722 million compared with INR 13.082 million for the same period a year ago. Profit from ordinary activities before tax was INR 13.499 million compared with INR 9.026 million for the same period a year ago. Net profit was INR 10.510 million or INR 0.62 per basic and diluted share before and after extraordinary items compared with INR 6.583 million or INR 0.39 per basic and diluted share before and after extraordinary items for the same period a year ago.

Aarey Drugs & Pharmaceuticals Ltd., Board Meeting, May 30, 2014

Aarey Drugs & Pharmaceuticals Ltd., Board Meeting, May 30, 2014. Agenda: To approve standalone audited earnings results for the fourth quarter and full year ended March 31, 2014.

Aarey Drugs & Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013

Aarey Drugs & Pharmaceuticals Ltd. announced unaudited earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company reported net income from operations of INR 583.387 million against INR 482.476 million for the same period a year ago. Operating profit before interest was INR 3.730 million against INR 4.596 million a year ago. Profit from ordinary activities before tax was INR 2.514 million against INR 2.863 million a year ago. Net profit for the period was INR 2.514 million or INR 0.15 per basis and diluted share against INR 2.863 million or INR 0.17 per basis and diluted share a year ago. For the nine months, the company reported net income from operations of INR 1,627.359 million against INR 1,232.291 million for the same period a year ago. Operating profit before interest was INR 15.147 million against INR 16.635 million a year ago. Profit from ordinary activities before tax was INR 14.514 million against INR 11.970 million a year ago. Net profit for the period was INR 13.014 million or INR 0.78 per basis and diluted share against INR 11.970 million or INR 0.71 per basis and diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AD:IN 16.23 INR -1.80

AD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AD.
View Industry Companies
 

Industry Analysis

AD

Industry Average

Valuation AD Industry Range
Price/Earnings 28.9x
Price/Sales 0.2x
Price/Book -- Not Meaningful
Price/Cash Flow 18.0x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AAREY DRUGS & PHARMACEUT, please visit www.aareydrugs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.